1015. Gastrointestinal (GI) Adverse Events With Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Through Week 96: An AMBER Post Hoc Analysis

BACKGROUND: Ritonavir boosted protease inhibitors have been associated with GI intolerance. A post hoc analysis was conducted to assess the GI profile of D/C/F/TAF in treatment naïve patients. METHODS: The phase 3 AMBER trial (ClinicalTrials.gov: NCT02431247) enrolled treatment naïve patients random...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunn, Keith, Huang, Yangxin, Baugh, Bryan, Bejou, Nika, Luo, Donghan, Campbell, Jennifer, Anderson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776806/
http://dx.doi.org/10.1093/ofid/ofaa439.1201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776806/
http://dx.doi.org/10.1093/ofid/ofaa439.1201

Ejemplares similares